Evidence map›Paper›PMID 29113144›Full record

ArticleInternational journal of molecular sciences2017

Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.

Olga V Masalova, Ekaterina I Lesnova, Pavel N Solyev, Natalia F Zakirova, Vladimir S Prassolov, Sergey N Kochetkov, Alexander V Ivanov, Alla A Kushch

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Role of Bcl-xL Protein in Viral Infections.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Olga V MasalovaIvanovsky Institute of Virology, Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow 123098, Russia. ol.mas@mail.ru.ORCID 0000-0001-5571-5669
Ekaterina I LesnovaIvanovsky Institute of Virology, Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow 123098, Russia. wolf252006@yandex.ru.
Pavel N SolyevEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia. solyev@gmail.com.ORCID 0000-0002-5546-4975
Natalia F ZakirovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia. nat_zakirova@mail.ru.
Vladimir S PrassolovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia. prassolov45@mail.ru.
Sergey N KochetkovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia. kochet@eimb.ru.
Alexander V IvanovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia. aivanov@yandex.ru.ORCID 0000-0002-5659-9679
Alla A KushchIvanovsky Institute of Virology, Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow 123098, Russia. vitallku@mail.ru.ORCID 0000-0002-3396-5533
Engelhardt Institute of Molecular Biology · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hepatitis C virus (HCV) causes chronic liver disease leading to fibrosis, cirrhosis, and hepatocellular carcinoma. HCV infection triggers various types of cell death which contribute to hepatitis C pathogenesis. However, much is still unknown about the impact of viral proteins on them. Here we present the results of simultaneous immunocytochemical analysis of markers of apoptosis, autophagy, and necrosis in Huh7.5 cells expressing individual HCV proteins or their combinations, or harboring the virus replicon. Stable replication of the full-length HCV genome or transient expression of its core, Е1/Е2, NS3 and NS5B led to the death of 20-47% cells, 72 h posttransfection, whereas the expression of the NS4A/B, NS5A or NS3-NS5B polyprotein did not affect cell viability. HCV proteins caused different impacts on the activation of caspases-3, -8 and -9 and on DNA fragmentation. The structural core and E1/E2 proteins promoted apoptosis, whereas non-structural NS4A/B, NS5A, NS5B suppressed apoptosis by blocking various members of the caspase cascade. The majority of HCV proteins also enhanced autophagy, while NS5A also induced necrosis. As a result, the death of Huh7.5 cells expressing the HCV core was induced via apoptosis, the cells expressing NS3 and NS5B via autophagy-associated death, and the cells expressing E1/E2 glycoproteins or harboring HCV the replicon via both apoptosis and autophagy.

Indexed as

ApoptosisAutophagyCarcinoma, HepatocellularCaspasesCell Line, TumorGene Expression Regulation, NeoplasticGenome, ViralHepacivirusHepatitis CHumansLiver CirrhosisLiver NeoplasmsRNA-Dependent RNA PolymeraseSignal TransductionTransfectionViral Nonstructural ProteinsCaspasesNS-5 protein, hepatitis C virusRNA-Dependent RNA PolymeraseViral Nonstructural Proteinsapoptosisautophagycaspasehepatitis C virushepatoma Huh7.5 cellsnecrosisreplicon

Identifiers

PMID29113144
PMCPMC5713315
OpenAlexW2767237799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.